- [Primary central nervous system lymphoma as a neurological manifestation of AIDS stage]S Happe
Klinik und Poliklinik fur Neurologie, Westfalische Wilhelms Universitat Munster, Albert Schweitzer Strasse 33, 48129 Munster
Nervenarzt 72:136-42. 2001..The main criteria for differential diagnosis from other secondary neuromanifestations such as cerebral toxoplasmosis, progressive multifocal leukoencephalopathy, abscesses, and infarctions are described...
- The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective studyS Happe
Department of Neurology, University of Muenster, Germany
J Neurol 248:1062-7. 2001..The aim of this study was the evaluation of sleep disturbances and the quality of life (QoL) in PD patients with different dopaminergic treatment strategies...
- Treatment of idiopathic restless legs syndrome (RLS) with gabapentinS Happe
Department of Clinical Neurology, University of Vienna, Austria
Neurology 57:1717-9. 2001..Polysomnographic data showed a reduction of periodic leg movements during sleep (PLMS) (p = 0.003) and PLMS index (p = 0.001). The authors conclude that gabapentin provides a well-tolerated and effective treatment of idiopathic RLS...
- [Sleep-related headaches]S Happe
Klinik und Poliklinik fur Neurologie, Westfalische Wilhelms Universitat Munster, Bundesrepublik Deutschland
Wien Klin Wochenschr 113:259-65. 2001..Except for the latter, they were included in the International Classification of Sleep Disorders and are described in this article...
- Sleep disorders and depression in patients with Parkinson's diseaseS Happe
Department of Neurology, University of Vienna, Austria
Acta Neurol Scand 104:275-80. 2001..The strong association of depression, disease severity and sleep disorders in PD patients underlines the importance of identifying and treating both conditions in these patients...
- Comorbidity of migraine and restless legs syndrome--a case-control studyA M Rhode
Department of Neurology, Klinikum Bremen Ost and University of Göttingen, Gottingen, Germany
Cephalalgia 27:1255-60. 2007..There is an association between RLS and migraine and, in addition, a co-association with depression. The underlying mechanism, however, remains undetermined and might be related to a dysfunction of dopaminergic metabolism in migraine...
- Intravenous levetiracetam: a new treatment alternative for refractory status epilepticusG Moddel
Department of Neurology, University of Munster, Albert Schweitzer Strasse 33, 48129 Munster, Germany
J Neurol Neurosurg Psychiatry 80:689-92. 2009..This study suggests that LEV-iv may be a safe and efficacious treatment of SE. Prospective and controlled trials are imperative to confirm these preliminary findings...
- Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR)W H Oertel
Department of Neurology, Center of Nervous Diseases, Philipps University Marburg, Rudolf Bultmann Str 8, D 35033 Marburg, Germany
Neurology 67:1040-6. 2006..To assess the efficacy and safety of the dopamine agonist cabergoline in the treatment of patients with idiopathic restless legs syndrome (CATOR study)...
- Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleepG G Tribl
Department of Clinical Neurology, University of Vienna, Vienna General Hospital, Austria
Nucl Med Commun 25:55-60. 2004..Structures other than striatal D2 receptors are discussed as possible causes of the treatment effects in RLS...
- Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in EuropeWolfgang H Oertel
Department of Neurology, Philipps University, Rudolf Bultmann Strasse 8, D 35039 Marburg, Germany
Sleep Med 9:228-39. 2008..In a pilot placebo-controlled study, low dosages of 0.5-2mg/24h rotigotine showed a dose-dependent beneficial effect in restless legs syndrome (RLS) patients...
- Axonal polyneuropathy in obstructive sleep apnoeaP Ludemann
Department of Neurology, University of Munster, Albert Schweitzer Strasse 33, D 48129 Munster, Germany
J Neurol Neurosurg Psychiatry 70:685-7. 2001..It is assumed that recurrent intermittent hypoxaemia in OSA is an independent risk factor for axonal damage of peripheral nerves...